ARTICLE | Company News
Ironwood, AstraZeneca sales and marketing update
January 21, 2013 8:00 AM UTC
Ironwood said in its 4Q12 earnings that it received rights from AstraZeneca to co-promote Nexium esomeprazole in the U.S. The proton pump inhibitor (PPI) delayed-release capsules are approved in more...